Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells.
Glycolipids were depleted from the membranes of human A431 cells using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), an inhibitor of glucosylceramide synthetase. After 6 days of culture in the presence of 5 microM D-threo-PDMP, glycolipid content was reduced to approximately 5% of control levels. By contrast, synthesis per cell of phosphatidylcholine, sphingomyelin, triglycerides, and glycoprotein was relatively unchanged in PDMP-treated cells. In parallel with glycolipid depletion, PDMP-treated cells exhibited a rapid loss of epithelial cell morphology, a reduced rate of cell growth, and inhibition of cell-substrate adhesion. The effects of D-threo-PDMP on cell morphology and substrate adhesion were blocked by exogenous GM3 addition and were not observed with L-threo-PDMP (a relatively inactive enantiomer). Fluorescence photobleaching and recovery (FPR) was used to investigate the hypothesis that glycolipids influence cell behavior, in part, by changing the diffusion characteristics of membrane proteins and lipids. Diffusion coefficients and mobile fractions of two integral membrane proteins, the EGF receptor and a class I MHC antigen, did not differ significantly between control and PDMP-treated cells. Diffusion coefficients of lipid probes, NBD-PC and fluorescent GM1 ganglioside, were similarly unaffected by glycolipid depletion. However, lipid probes did show a significant increase in mobile fraction (the fraction of lipids that are free to diffuse) in PDMP-treated cells. This increase was blocked by culturing cells in the presence of exogenous GM3 ganglioside. The results suggest that glycolipids play a role in the formation of lipid domains in A431 cell membranes. Glycolipid-mediated changes in membrane lipid organization may influence receptor activation and transmembrane signaling, leading to changes in cell growth, morphology, and adhesion.
Barbour
S
S
Department of Biology, Johns Hopkins University, Baltimore, Maryland 21218.
Edidin
M
M
Felding-Habermann
B
B
Taylor-Norton
J
J
Radin
N S
NS
Fenderson
B A
BA
D002294:Carcinoma, Squamous Cell; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002518:Ceramides / Q000494:pharmacology; D004058:Diffusion; D005434:Flow Cytometry; D006017:Glycolipids / Q000378:metabolism*; D016695:Glycosyltransferases / Q000037:antagonists & inhibitors*; D006801:Humans; D008563:Membrane Lipids / Q000378:metabolism; D008856:Microscopy, Fluorescence; D009025:Morpholines / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000166:cytology
D002518:Ceramides; D006017:Glycolipids; D008563:Membrane Lipids; D009025:Morpholines; D011506:Proteins; C033110:RV 538; D016695:Glycosyltransferases